Loading…
Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt
Enterococci commonly inhabit the gastrointestinal tract of both human and animals; however, they have emerged as a leading cause of several infections with substantial morbidity and mortality. Their ability to acquire resistance combined with intrinsic resistance to various antimicrobials makes trea...
Saved in:
Published in: | Infection and drug resistance 2019-05, Vol.12, p.1113-1125 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c545t-4749e9d97ed774f519eda7174d05c358a75dd65e94d6726ac957f7b600dee82c3 |
---|---|
cites | |
container_end_page | 1125 |
container_issue | |
container_start_page | 1113 |
container_title | Infection and drug resistance |
container_volume | 12 |
creator | Said, Heba Shehta Abdelmegeed, Eman Salama |
description | Enterococci commonly inhabit the gastrointestinal tract of both human and animals; however, they have emerged as a leading cause of several infections with substantial morbidity and mortality. Their ability to acquire resistance combined with intrinsic resistance to various antimicrobials makes treatment of enterococcal infections challenging.
The aim of the study was to evaluate the antimicrobial resistance pattern, and assess the prevalence of multidrug resistance (MDR) and extensive drug resistance (XDR) among enterococcal isolates, collected from different clinical sources, in Mansoura University Hospitals, Egypt.
Antibiotic sensitivity testing revealed elevated levels of resistance among enterococcal clinical isolates (N=103). All
(N=32) and 74.6% of
(N=71) were MDR, while two
and four
isolates were XDR. High level gentamicin resistance was detected in 79.6%, most of them carried the
gene. High level streptomycin resistance was seen in 36.9%, of which 52.6% carried the
gene. Resistance to macrolides and lincosamides were mediated by
(92.2%) and
(42.7%).
,
, and
genes were detected among tetracyclines resistant isolates. Resistance to vancomycin was detected in 15.5%, where
and
gene clusters were detected in VRE isolates. Ten isolates (9.7%) were resistant to linezolid, eight of which harbored the
gene. Vancomycin and linezolid resistant enterococci were more likely to exhibit strong/moderate biofilm formation than vancomycin and linezolid sensitive ones.
Elevated levels of resistance to different classes of antimicrobial agents and emergence of MDR and XDR strains pose a major threat with limited therapeutic options for infections caused by this emerging pathogen. |
doi_str_mv | 10.2147/IDR.S189341 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ed9c634f38b4467190cbcb0a68d0fc6b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A610675978</galeid><doaj_id>oai_doaj_org_article_ed9c634f38b4467190cbcb0a68d0fc6b</doaj_id><sourcerecordid>A610675978</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-4749e9d97ed774f519eda7174d05c358a75dd65e94d6726ac957f7b600dee82c3</originalsourceid><addsrcrecordid>eNptkl1rFDEUhgdRbKm98l4GBCnIrsnka3IjlLrqQkHw4zpkkjOzKTPJmmSK_fdm3bXsoslFDuc85yUneavqJUbLBlPxbv3h6_IbbiWh-El1jrFoF1wK8vQoPqsuU7pDZRHJqWieV2cEY9wKTM6raTVBHMAbqENfT_OYnY3zUEdILmW9y2tva_iVwSd3D_U_1Sn4oQafIQYTjNFjbUbn3S5wKYw6Q6qdr1fDwza_qJ71ekxweTgvqh8fV99vPi9uv3xa31zfLgyjLC-ooBKklQKsELRnWILVAgtqETOEtVowazkDSS0XDddGMtGLjiNkAdrGkItqvde1Qd-pbXSTjg8qaKf-JEIclI7ZmREUWGk4oT1pO0q5wBKZznRI89ai3vCuaL3fa23nbgJryqhRjyeipxXvNmoI94ozjBqCisDVQSCGnzOkrCaXDIyj9hDmpJqGNIUUnBX09R4ddLma830oimaHq2uOERdMirZQy_9QZVuYnAkeelfyJw1vjho2oMe8KV8zZxd8OgXf7kETQ0oR-scxMVI7v6niN3XwW6FfHb_MI_vXXeQ39kbQoQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2232102765</pqid></control><display><type>article</type><title>Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt</title><source>Taylor & Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Said, Heba Shehta ; Abdelmegeed, Eman Salama</creator><creatorcontrib>Said, Heba Shehta ; Abdelmegeed, Eman Salama</creatorcontrib><description>Enterococci commonly inhabit the gastrointestinal tract of both human and animals; however, they have emerged as a leading cause of several infections with substantial morbidity and mortality. Their ability to acquire resistance combined with intrinsic resistance to various antimicrobials makes treatment of enterococcal infections challenging.
The aim of the study was to evaluate the antimicrobial resistance pattern, and assess the prevalence of multidrug resistance (MDR) and extensive drug resistance (XDR) among enterococcal isolates, collected from different clinical sources, in Mansoura University Hospitals, Egypt.
Antibiotic sensitivity testing revealed elevated levels of resistance among enterococcal clinical isolates (N=103). All
(N=32) and 74.6% of
(N=71) were MDR, while two
and four
isolates were XDR. High level gentamicin resistance was detected in 79.6%, most of them carried the
gene. High level streptomycin resistance was seen in 36.9%, of which 52.6% carried the
gene. Resistance to macrolides and lincosamides were mediated by
(92.2%) and
(42.7%).
,
, and
genes were detected among tetracyclines resistant isolates. Resistance to vancomycin was detected in 15.5%, where
and
gene clusters were detected in VRE isolates. Ten isolates (9.7%) were resistant to linezolid, eight of which harbored the
gene. Vancomycin and linezolid resistant enterococci were more likely to exhibit strong/moderate biofilm formation than vancomycin and linezolid sensitive ones.
Elevated levels of resistance to different classes of antimicrobial agents and emergence of MDR and XDR strains pose a major threat with limited therapeutic options for infections caused by this emerging pathogen.</description><identifier>ISSN: 1178-6973</identifier><identifier>EISSN: 1178-6973</identifier><identifier>DOI: 10.2147/IDR.S189341</identifier><identifier>PMID: 31118713</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Aminoglycosides ; Antibacterial agents ; antibiotic resistance ; Antibiotics ; biofilm formation ; Drug resistance ; Drug therapy ; Egypt ; Enterococcal infections ; Enterococci ; Gastrointestinal system ; Genes ; Health aspects ; Hospital patients ; Hospitals ; Imipenem ; Infection ; Linezolid ; Linezolid resistant enterococci ; MDR enterococci ; Meropenem ; Microbial drug resistance ; Morbidity ; Original Research ; RAPD typing ; Tetracyclines ; Vancomycin ; VRE ; XDR enterococci</subject><ispartof>Infection and drug resistance, 2019-05, Vol.12, p.1113-1125</ispartof><rights>COPYRIGHT 2019 Dove Medical Press Limited</rights><rights>2019 Said and Abdelmegeed. This work is published and licensed by Dove Medical Press Limited 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-4749e9d97ed774f519eda7174d05c358a75dd65e94d6726ac957f7b600dee82c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510230/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510230/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,36990,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31118713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Said, Heba Shehta</creatorcontrib><creatorcontrib>Abdelmegeed, Eman Salama</creatorcontrib><title>Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt</title><title>Infection and drug resistance</title><addtitle>Infect Drug Resist</addtitle><description>Enterococci commonly inhabit the gastrointestinal tract of both human and animals; however, they have emerged as a leading cause of several infections with substantial morbidity and mortality. Their ability to acquire resistance combined with intrinsic resistance to various antimicrobials makes treatment of enterococcal infections challenging.
The aim of the study was to evaluate the antimicrobial resistance pattern, and assess the prevalence of multidrug resistance (MDR) and extensive drug resistance (XDR) among enterococcal isolates, collected from different clinical sources, in Mansoura University Hospitals, Egypt.
Antibiotic sensitivity testing revealed elevated levels of resistance among enterococcal clinical isolates (N=103). All
(N=32) and 74.6% of
(N=71) were MDR, while two
and four
isolates were XDR. High level gentamicin resistance was detected in 79.6%, most of them carried the
gene. High level streptomycin resistance was seen in 36.9%, of which 52.6% carried the
gene. Resistance to macrolides and lincosamides were mediated by
(92.2%) and
(42.7%).
,
, and
genes were detected among tetracyclines resistant isolates. Resistance to vancomycin was detected in 15.5%, where
and
gene clusters were detected in VRE isolates. Ten isolates (9.7%) were resistant to linezolid, eight of which harbored the
gene. Vancomycin and linezolid resistant enterococci were more likely to exhibit strong/moderate biofilm formation than vancomycin and linezolid sensitive ones.
Elevated levels of resistance to different classes of antimicrobial agents and emergence of MDR and XDR strains pose a major threat with limited therapeutic options for infections caused by this emerging pathogen.</description><subject>Aminoglycosides</subject><subject>Antibacterial agents</subject><subject>antibiotic resistance</subject><subject>Antibiotics</subject><subject>biofilm formation</subject><subject>Drug resistance</subject><subject>Drug therapy</subject><subject>Egypt</subject><subject>Enterococcal infections</subject><subject>Enterococci</subject><subject>Gastrointestinal system</subject><subject>Genes</subject><subject>Health aspects</subject><subject>Hospital patients</subject><subject>Hospitals</subject><subject>Imipenem</subject><subject>Infection</subject><subject>Linezolid</subject><subject>Linezolid resistant enterococci</subject><subject>MDR enterococci</subject><subject>Meropenem</subject><subject>Microbial drug resistance</subject><subject>Morbidity</subject><subject>Original Research</subject><subject>RAPD typing</subject><subject>Tetracyclines</subject><subject>Vancomycin</subject><subject>VRE</subject><subject>XDR enterococci</subject><issn>1178-6973</issn><issn>1178-6973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkl1rFDEUhgdRbKm98l4GBCnIrsnka3IjlLrqQkHw4zpkkjOzKTPJmmSK_fdm3bXsoslFDuc85yUneavqJUbLBlPxbv3h6_IbbiWh-El1jrFoF1wK8vQoPqsuU7pDZRHJqWieV2cEY9wKTM6raTVBHMAbqENfT_OYnY3zUEdILmW9y2tva_iVwSd3D_U_1Sn4oQafIQYTjNFjbUbn3S5wKYw6Q6qdr1fDwza_qJ71ekxweTgvqh8fV99vPi9uv3xa31zfLgyjLC-ooBKklQKsELRnWILVAgtqETOEtVowazkDSS0XDddGMtGLjiNkAdrGkItqvde1Qd-pbXSTjg8qaKf-JEIclI7ZmREUWGk4oT1pO0q5wBKZznRI89ai3vCuaL3fa23nbgJryqhRjyeipxXvNmoI94ozjBqCisDVQSCGnzOkrCaXDIyj9hDmpJqGNIUUnBX09R4ddLma830oimaHq2uOERdMirZQy_9QZVuYnAkeelfyJw1vjho2oMe8KV8zZxd8OgXf7kETQ0oR-scxMVI7v6niN3XwW6FfHb_MI_vXXeQ39kbQoQ</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Said, Heba Shehta</creator><creator>Abdelmegeed, Eman Salama</creator><general>Dove Medical Press Limited</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20190501</creationdate><title>Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt</title><author>Said, Heba Shehta ; Abdelmegeed, Eman Salama</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-4749e9d97ed774f519eda7174d05c358a75dd65e94d6726ac957f7b600dee82c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aminoglycosides</topic><topic>Antibacterial agents</topic><topic>antibiotic resistance</topic><topic>Antibiotics</topic><topic>biofilm formation</topic><topic>Drug resistance</topic><topic>Drug therapy</topic><topic>Egypt</topic><topic>Enterococcal infections</topic><topic>Enterococci</topic><topic>Gastrointestinal system</topic><topic>Genes</topic><topic>Health aspects</topic><topic>Hospital patients</topic><topic>Hospitals</topic><topic>Imipenem</topic><topic>Infection</topic><topic>Linezolid</topic><topic>Linezolid resistant enterococci</topic><topic>MDR enterococci</topic><topic>Meropenem</topic><topic>Microbial drug resistance</topic><topic>Morbidity</topic><topic>Original Research</topic><topic>RAPD typing</topic><topic>Tetracyclines</topic><topic>Vancomycin</topic><topic>VRE</topic><topic>XDR enterococci</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Said, Heba Shehta</creatorcontrib><creatorcontrib>Abdelmegeed, Eman Salama</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJÂ Directory of Open Access Journals</collection><jtitle>Infection and drug resistance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Said, Heba Shehta</au><au>Abdelmegeed, Eman Salama</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt</atitle><jtitle>Infection and drug resistance</jtitle><addtitle>Infect Drug Resist</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>12</volume><spage>1113</spage><epage>1125</epage><pages>1113-1125</pages><issn>1178-6973</issn><eissn>1178-6973</eissn><abstract>Enterococci commonly inhabit the gastrointestinal tract of both human and animals; however, they have emerged as a leading cause of several infections with substantial morbidity and mortality. Their ability to acquire resistance combined with intrinsic resistance to various antimicrobials makes treatment of enterococcal infections challenging.
The aim of the study was to evaluate the antimicrobial resistance pattern, and assess the prevalence of multidrug resistance (MDR) and extensive drug resistance (XDR) among enterococcal isolates, collected from different clinical sources, in Mansoura University Hospitals, Egypt.
Antibiotic sensitivity testing revealed elevated levels of resistance among enterococcal clinical isolates (N=103). All
(N=32) and 74.6% of
(N=71) were MDR, while two
and four
isolates were XDR. High level gentamicin resistance was detected in 79.6%, most of them carried the
gene. High level streptomycin resistance was seen in 36.9%, of which 52.6% carried the
gene. Resistance to macrolides and lincosamides were mediated by
(92.2%) and
(42.7%).
,
, and
genes were detected among tetracyclines resistant isolates. Resistance to vancomycin was detected in 15.5%, where
and
gene clusters were detected in VRE isolates. Ten isolates (9.7%) were resistant to linezolid, eight of which harbored the
gene. Vancomycin and linezolid resistant enterococci were more likely to exhibit strong/moderate biofilm formation than vancomycin and linezolid sensitive ones.
Elevated levels of resistance to different classes of antimicrobial agents and emergence of MDR and XDR strains pose a major threat with limited therapeutic options for infections caused by this emerging pathogen.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>31118713</pmid><doi>10.2147/IDR.S189341</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1178-6973 |
ispartof | Infection and drug resistance, 2019-05, Vol.12, p.1113-1125 |
issn | 1178-6973 1178-6973 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_ed9c634f38b4467190cbcb0a68d0fc6b |
source | Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central |
subjects | Aminoglycosides Antibacterial agents antibiotic resistance Antibiotics biofilm formation Drug resistance Drug therapy Egypt Enterococcal infections Enterococci Gastrointestinal system Genes Health aspects Hospital patients Hospitals Imipenem Infection Linezolid Linezolid resistant enterococci MDR enterococci Meropenem Microbial drug resistance Morbidity Original Research RAPD typing Tetracyclines Vancomycin VRE XDR enterococci |
title | Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T03%3A39%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emergence%20of%20multidrug%20resistance%20and%20extensive%20drug%20resistance%20among%20enterococcal%20clinical%20isolates%20in%20Egypt&rft.jtitle=Infection%20and%20drug%20resistance&rft.au=Said,%20Heba%20Shehta&rft.date=2019-05-01&rft.volume=12&rft.spage=1113&rft.epage=1125&rft.pages=1113-1125&rft.issn=1178-6973&rft.eissn=1178-6973&rft_id=info:doi/10.2147/IDR.S189341&rft_dat=%3Cgale_doaj_%3EA610675978%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c545t-4749e9d97ed774f519eda7174d05c358a75dd65e94d6726ac957f7b600dee82c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2232102765&rft_id=info:pmid/31118713&rft_galeid=A610675978&rfr_iscdi=true |